GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] proposal — a flair for 503A posts — 57 comments in the full submission. View in context.
3k
c/compounding·submitted 1 year ago by u/solene_eriksen

[Meta] proposal — a flair for 503A posts

Regulatorybranch of 6 comments

proposal — a flair for 503A posts. Disagreement welcome, but bring a concrete alternative wording. A beyond-use date derived from published stability data means something different from one assigned by default rule. Asking which is a fair question and the answer is usually available. Salt form matters for mass: a…

Read the full submission and all 57 comments →

This branch

6 comments, started 1 year ago
u/honest_syringe_2025175 points·1 year ago

the pharmacy and the prescriber are two separate questions

replysharereportpermalink
u/solene_eriksenOP92 points·1 year ago

503A or 503B — do you know which?

replysharereportpermalink
u/solene_eriksenOP61 points·1 year ago

503A is patient-specific, 503B is outsourcing facility, they are not the same thing

replysharereportpermalink
u/santiago_rasmussen26 points·1 year ago

potency testing on the finished preparation is the thing to ask for

replysharereportpermalink
u/marit_mwangi51 points·1 year ago

the price difference is mostly the intake, not the vial

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →